Last reviewed · How we verify

NCT07072260

Effect of Activator-Assisted Talocrural Manipulation on Performance in Elite Volleyball Players

Completed NA Last updated 18 July 2025
What this trial tests

NA trial testing Sham Stroking in Joint Manipulation in 60 participants. Completed in 30 May 2025.

Timeline
10 May 2025
Primary endpoint
20 May 2025
30 May 2025

Quick facts

Lead sponsorAnkara Yildirim Beyazıt University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date10 May 2025
Primary completion20 May 2025
Estimated completion30 May 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ankara Yildirim Beyazıt University

Who can join

Adults 15 to 25, male only, with Joint Manipulation or Range of Motion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial aims to evaluate the acute effects of activator-assisted talocrural joint manipulation on joint range of motion, dynamic balance, vertical and horizontal jump performance, and weight transfer parameters in elite male volleyball players aged 18-25. The study compares a manipulation group with a sham control group and assesses performance metrics before and after the intervention.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Investigation of the effect of activator-assisted talocrural joint manipulation on acute sports performance parameters in elite male volleyball players.
    Haksever B, Hajighorbani K, Cakir CH, Isguzar MG, et al · · 2025 · PMID 41053891 · DOI 10.1186/s13102-025-01358-1

Verify or expand the search:

Other Ankara Yildirim Beyazıt University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07072260.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing